Cargando…

Influence of Three Probiotics Strains, Lactobacillus rhamnosus GG, Bifidobacterium animalis subsp. Lactis BB-12 and Saccharomyces boulardii CNCM I-745 on the Biochemical and Haematological Profiles and Body Weight of Healthy Rabbits

SIMPLE SUMMARY: Currently, probiotics are used as growth promoters on a large scale to improve the productivity of several animals’ species within the aim of reducing the presence of antibiotic residues in animal products consumed by humans. Several reports evidenced the positive effect of probiotic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadja, Louiza, Dib, Amira Leila, Lakhdara, Nedjoua, Bouaziz, Assia, Espigares, Elena, Gagaoua, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615081/ https://www.ncbi.nlm.nih.gov/pubmed/34827188 http://dx.doi.org/10.3390/biology10111194

Ejemplares similares

Study of Probiotic Effects of Bifidobacterium animalis subsp. lactis BB-12 and Lactobacillus plantarum 299v Strains on Biochemical and Morphometric Parameters of Rabbits after Obesity Induction
por: Bouaziz, Assia, et al.
Publicado: (2021)

Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system
por: Stier, Heike, et al.
Publicado: (2016)

In Vitro Effects of Live and Heat-Inactivated Bifidobacterium animalis Subsp. Lactis, BB-12 and Lactobacillus rhamnosus GG on Caco-2 Cells
por: Castro-Herrera, Vivian M., et al.
Publicado: (2020)

Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections
por: Czerucka, Dorota, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review
por: Gopalan, Sarath, et al.
Publicado: (2023)

The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015)

Correction: Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS
por: Brun, Paola, et al.
Publicado: (2017)

Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review
por: Moré, Margret I, et al.
Publicado: (2018)

Beneficial effects of Saccharomyces boulardii CNCM I-745 on clinical disorders associated with intestinal barrier disruption
por: Terciolo, Chloe, et al.
Publicado: (2019)

Restitution of gut microbiota in Ugandan children administered with probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12) during treatment for severe acute malnutrition
por: Castro-Mejía, Josué L., et al.
Publicado: (2020)

The Saccharomyces boulardii CNCM I-745 Strain Shows Protective Effects against the B. anthracis LT Toxin
por: Pontier-Bres, Rodolphe, et al.
Publicado: (2015)

Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis – a review
por: Moré, Margret I, et al.
Publicado: (2015)

Specific targeting of inflammatory osteoclastogenesis by the probiotic yeast S. boulardii CNCM I-745 reduces bone loss in osteoporosis
por: Madel, Maria-Bernadette, et al.
Publicado: (2023)

1681 Randomized Clinical Trial of the Recovery of Probiotics Lactobacillus rhamnosus GG (LGG) and Bifidobacterium animalis subspecies lactis (BB-12) from the Gastrointestinal (GI) Tract of Healthy Volunteers
por: Poutsiaka, Debra D., et al.
Publicado: (2014)

Saccharomyces boulardii CNCM I-745 Modulates the Fecal Bile Acids Metabolism During Antimicrobial Therapy in Healthy Volunteers
por: Kelly, Ciaran Patrick, et al.
Publicado: (2019)

Saccharomyces boulardii CNCM I-745 supplementation during and after antibiotic treatment positively influences the bacterial gut microbiota
por: Spatz, Madeleine, et al.
Publicado: (2023)

Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases
por: Kaźmierczak-Siedlecka, Karolina, et al.
Publicado: (2020)

Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults
por: Toiviainen, Aino, et al.
Publicado: (2014)

Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
por: Kabbani, Toufic A., et al.
Publicado: (2016)

Saccharomyces boulardii Strain CNCM I-745 Modifies the Mononuclear Phagocytes Response in the Small Intestine of Mice Following Salmonella Typhimurium Infection
por: Ibáñez, Lidia, et al.
Publicado: (2019)

Retrospective analysis of EMR database to assess the effectiveness of Saccharomyces boulardii CNCM I-745 in children with acute diarrhoea during routine clinical practice
por: Ragavan, P.S.K., et al.
Publicado: (2020)

Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition
por: Lacotte, Pierre-Alexandre, et al.
Publicado: (2022)

The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®)
por: Jungersen, Mikkel, et al.
Publicado: (2014)

Effect of Chilled Storage on Antioxidant Capacities and Volatile Flavors of Synbiotic Yogurt Made with Probiotic Yeast Saccharomyces boulardii CNCM I-745 in Combination with Inulin
por: Sarwar, Abid, et al.
Publicado: (2022)

Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis
por: Altcheh, Jaime, et al.
Publicado: (2022)

Effects of Probiotic Fermented Fruit Juice-Based Biotransformation by Lactic Acid Bacteria and Saccharomyces boulardii CNCM I-745 on Anti-Salmonella and Antioxidative Properties
por: Laosee, Wanida, et al.
Publicado: (2022)

Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial
por: Salazar-Parra, Marcela AG, et al.
Publicado: (2023)

UPLC-Q-TOF-MS based metabolomics and chemometric analyses for green tea fermented with Saccharomyces boulardii CNCM I-745 and Lactiplantibacillus plantarum 299V
por: Wang, Rui, et al.
Publicado: (2022)

Updated Genome Sequence for the Probiotic Bacterium Bifidobacterium animalis subsp. lactis BB-12
por: Jensen, Kristian, et al.
Publicado: (2021)

Carboxylic acids in the hindgut of rats fed highly soluble inulin and Bifidobacterium lactis (Bb-12), Lactobacillus salivarius (UCC500) or Lactobacillus rhamnosus (GG)
por: Nilsson, Ulf, et al.
Publicado: (2007)

Identification of Restriction-Modification Systems of Bifidobacterium animalis subsp. lactis CNCM I-2494 by SMRT Sequencing and Associated Methylome Analysis
por: O′Connell Motherway, Mary, et al.
Publicado: (2014)

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice
por: Martín, Rebeca, et al.
Publicado: (2016)

Evaluation of culture media for counts of Bifidobacterium animalis subsp. lactis Bb 12in yoghurt after refrigerated storage
por: Fachin, Luciano, et al.
Publicado: (2008)

Influence of Dehydrated Wheat/Rice Cereal Matrices on Probiotic Activity of Bifidobacterium animalis ssp. lactis BB-12®(§)
por: Leboš-Pavunc, Andreja, et al.
Publicado: (2019)

Effects of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: protocol of a randomised controlled trial
por: Groele, Lidia, et al.
Publicado: (2017)

Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial
por: Groele, Lidia, et al.
Publicado: (2021)

The distinct effects of orally administered Lactobacillus rhamnosus GG and Lactococcus lactis subsp. lactis C59 on gene expression in the murine small intestine
por: Suzuki, Chise, et al.
Publicado: (2017)

Combination of the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis, BB-12 Has Limited Effect on Biomarkers of Immunity and Inflammation in Older People Resident in Care Homes: Results From the Probiotics to Reduce Infections iN CarE home reSidentS Randomized, Controlled Trial
por: Castro-Herrera, Vivian M., et al.
Publicado: (2021)

Genome Sequence of Lactobacillus rhamnosus Strain CNCM I-3698
por: Tareb, R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2d72pgqlv2pieb2ib5svaacprc